Sep 30, 2023

Acacia Q3 2023 Earnings Report

Reported financial results for Q3 2023.

Key Takeaways

Acacia Research Corporation reported consolidated revenue of $10.1 million for the quarter, a decrease compared to $15.9 million in the third quarter of 2022. The company recorded $12.2 million of net realized and unrealized gains during the quarter and a GAAP net income of $1.6 million, or a net loss of $0.03 per diluted share.

Consolidated revenue for the quarter was $10.1 million, compared to $15.9 million in the third quarter of 2022.

Net realized and unrealized gains of $12.2 million were recorded during the quarter.

A wholly owned subsidiary entered into an agreement to sell its shares of Arix Bioscience PLC for $57.1 million, expected to be completed in Q1 2024.

Acquired a majority stake in Benchmark Energy II LLC, an independent oil and gas company.

Total Revenue
$10.1M
Previous year: $15.9M
-36.4%
EPS
-$0.03
Previous year: $0.02
-250.0%
Gross Profit
$4.61M
Previous year: $5.95M
-22.4%
Cash and Equivalents
$415M
Previous year: $242M
+71.6%
Free Cash Flow
$1.15M
Previous year: $3.81M
-70.0%
Total Assets
$529M
Previous year: $485M
+9.0%

Acacia

Acacia

Acacia Revenue by Segment

Forward Guidance

Acacia is focused on acquiring and operating attractive businesses across the industrial, healthcare, energy, and mature technology sectors.

Positive Outlook

  • Acacia's value-creation strategy has accelerated.
  • Established a platform to acquire producing, cash generating oil and gas assets.
  • Reached an agreement to sell stake in the last public holding in their life science portfolio.
  • Acacia and new partners are already evaluating potential asset acquisitions.
  • The company is methodically advancing specific opportunities.

Revenue & Expenses

Visualization of income flow from segment revenue to net income